Myelin-induced experimental allergic encephalomyelitis in Lewis rats: Tumor necrosis factor α levels in serum and cerebrospinal fluid Immunohistochemical expression in glial cells and macrophages of optic nerve and spinal cord

Journal of Neuroimmunology

Volumn 64, Issue 1, 1996, Pages 55-61

  Villarroya, Henri ^a   Violleau, Karine ^a   Younes Chennoufi, Amena Ben ^a   Baumann, Nicole ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Experimental allergic encephalomyelitis; Optic nerve; Spinal cord; Tumor necrosis factor

Indexed keywords

MYELIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GLIA CELL; MACROPHAGE; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RAT; SPINAL CORD;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GUINEA PIGS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MYELIN SHEATH; NEUROGLIA; OPTIC NERVE; RATS; RATS, INBRED LEW; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030034011     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(95)00151-4     Document Type: Article

References (23)

1. Aderka, D., Engelmann, H., Homik, V., Skornick, Y., Levo, Y., Wallach, D. and Kushtai, G. (1991) Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res. 51, 5602-5607.
2. Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C. and Wallach, D. (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med. 175, 323-329.
3. Baker, D., Butler, D., Scallon, B.J., O'Neill, J.K., Turk, J.L. and Feldmann, M. (1994) Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24, 2040-2048.
4. Beutler, B. and Cerami, A. (1986) Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 320, 584-588.
5. Beutler, B., Krochin, N., Milsark, I.W., Luedke, Ch. and Cerami, A. (1986) Control of cachectin (tumor necrosis factor) synthesis: mechanism of endotoxin resistance. Science 232, 977-980.
6. Beyaert, R., Vanhaesebroeck, B., Suffys, Ph., Van Roy, F. and Fiers, W. (1989) Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo. Proc. Natl. Acad. Sci, USA 86, 9494-9498.
7. Brosnan, C.F., Selmaj, K. and Raine, C.S. (1988) Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J. Neuroimmunol. 18, 87-94.
8. Brosnan, C.F., Litwak, M.S., Schroeder, C.E., Selmaj, K., Raine, C.S. and Arezzo, J.C. (1989) Preliminary studies of cytokine-induced functional effects on the visual pathways in the rabbit. J. Neuroimmunol. 25, 227-239.
9. Butter, C., Baker, D., O'Neill, J.K. and Turk, J.L. (1991) Mononuclear cells trafficking and plasma protein extravasation into the CNS during chronic relapsing EAE in Biozzi AB/mice. J. Neurol. Sci. 104, 9-12.
10. Chung, I.Y., Norris, J.G. and Benveniste, E.N. (1991) Differential TNFα expression by astrocytes from EAE-susceptible and resistant rat strains. J. Exp. Med. 173, 801-811.
11. Fontana, A., Kristensen, F., Dubs, R., Gemsa, D. and Weber, E. (1982) Production of prostaglandin E and an IL-1-like factor by cultured astrocytes and glioma cells. J. Immunol. 129, 2413-2419.
12. Franciotta, D.M., Grimaldi, L.M.E., Martino, G.V., Piccolo, G., Bergamaschi, R., Citterio, A. and Melzi d'Eril, G.V. (1989) Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis. Ann. Neurol. 26, 787-789.
13. Kuroda, Y. and Shimamoto, Y. (1991) Human tumor necrosis factor α augments experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 34, 159-164.
14. Maimone, D., Gregory, S., Arnson, B.G.W. and Reder, A.T. (1991) Cytokine levels in the cerebrospinal fluid and serum of patients with MS. J. Neuroimmunol. 32, 67-74.
15. Martenson, R.E. (1984) A useful model for multiple sclerosis. In: B.C. Alvord Jr. (Ed.), Experimental Allergic Encephalomyelities, Vol. 146. Alan Liss, New York, NY, pp. 511-521.
16. Meager, A., Leung, H. and Wolley, J. (1989) Assays for tumor necrosis factor and related cytokines. J. Immunol. Methods 116, 1-17.
17. Namer, I.J., Steibel, J., Poulet, P., Armspach, J.P., Mohr, M., Maurs, Y. and Chambron, J. (1993) Blood-brain barrier breakdown in MBP-specific T cell induced EAE. Brain 116, 147-159.
18. Olsson, T. (1994) Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis. Eur. J. Neurol. 1, 7-19.
19. Ortiz-Ortiz, L. and Weigle, W.O. (1976) Cellular events in the induction of experimental allergic encephalomyelitis in rats. J. Exp. Med. 144, 604-616.
20. Owens, T. and Fazekas de St Groth, B. (1987) Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens. J. Immunol. 138, 2402-2409.
21. 2-induced down-modulation of the disease. Eur. J. Immunol. 18, 243-247.
22. --T lymphocytes. J. Immunol. 127, 1420-1423.
23. Powell, M.B. and Steinman, L. (1992) The role of lymphotoxin and TNF in demyelinating diseases of CNS. In: B. Beutler (Ed.), Tumor Necrosis Factors. Raven Press, New York, NY, pp. 355-369.